Deutsche Bank’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,202
| Closed | -$33K | – | 4210 |
|
|
2022
Q1 | $33K | Sell |
1,202
-143
| -11% | -$3.93K | ﹤0.01% | 3850 |
|
|
2021
Q4 | $61K | Buy |
1,345
+72
| +6% | +$3.27K | ﹤0.01% | 3790 |
|
|
2021
Q3 | $106K | Sell |
1,273
-2,046
| -62% | -$170K | ﹤0.01% | 3818 |
|
|
2021
Q2 | $315K | Buy |
+3,319
| New | +$315K | ﹤0.01% | 3490 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4854 |
|
|
2019
Q3 | – | Sell |
-463
| Closed | -$60K | – | 4916 |
|
|
2019
Q2 | $60K | Sell |
463
-1,257
| -73% | -$163K | ﹤0.01% | 4255 |
|
|
2019
Q1 | $288K | Buy |
1,720
+1,674
| +3,639% | +$280K | ﹤0.01% | 3713 |
|
|
2018
Q4 | $4K | Sell |
46
-36
| -44% | -$3.13K | ﹤0.01% | 4557 |
|
|
2018
Q3 | $18K | Sell |
82
-244
| -75% | -$53.6K | ﹤0.01% | 4598 |
|
|
2018
Q2 | $699K | Buy |
326
+205
| +169% | +$440K | ﹤0.01% | 3606 |
|
|
2018
Q1 | $300K | Buy |
+121
| New | +$300K | ﹤0.01% | 3892 |
|
|
2016
Q4 | – | Sell |
-52
| Closed | -$57K | – | 4557 |
|
|
2016
Q3 | $57K | Buy |
+52
| New | +$57K | ﹤0.01% | 3917 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4827 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4849 |
|
|
2014
Q3 | – | Sell |
-32
| Closed | -$60K | – | 5370 |
|
|
2014
Q2 | $60K | Buy |
32
+24
| +300% | +$45K | ﹤0.01% | 4489 |
|
|
2014
Q1 | $17K | Buy |
8
+4
| +100% | +$8.5K | ﹤0.01% | 4795 |
|
|
2013
Q4 | $8K | Sell |
4
-20
| -83% | -$40K | ﹤0.01% | 4760 |
|
|
2013
Q3 | $67K | Sell |
24
-26
| -52% | -$72.6K | ﹤0.01% | 4540 |
|
|
2013
Q2 | $461K | Buy |
+50
| New | +$461K | ﹤0.01% | 3220 |
|